New York can­cer cen­ter launch­es 'his­toric' JV to bring Cuban-de­vel­oped can­cer drugs to US

Some of the next wave of im­munother­a­pies de­signed to bol­ster check­point in­hibitors will orig­i­nate from Cu­ba — if Roswell Park Com­pre­hen­sive Can­cer Cen­ter’s lat­est ven­ture flour­ish­es …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER